Pisters LL - Search Results

1

Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results.

Pettaway CA, Pisters LL, Troncoso P, Slaton J, Finn L, Kamoi K, Logothetis CJ. Pettaway CA, et al. Among authors: pisters ll. J Clin Oncol. 2000 Mar;18(5):1050-7. doi: 10.1200/JCO.2000.18.5.1050. J Clin Oncol. 2000. PMID: 10694556 Clinical Trial.

2

Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.

Kagan J, Stein J, Babaian RJ, Joe YS, Pisters LL, Glassman AB, von Eschenbach AC, Troncoso P. Kagan J, et al. Among authors: pisters ll. Oncogene. 1995 Nov 16;11(10):2121-6. Oncogene. 1995. PMID: 7478532

3

Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience.

Pettaway CA, Pisters LL, Dinney CP, Jularbal F, Swanson DA, von Eschenbach AC, Ayala A. Pettaway CA, et al. Among authors: pisters ll. J Urol. 1995 Dec;154(6):1999-2003. J Urol. 1995. PMID: 7500444

4

Trisomy 7: a potential cytogenetic marker of human prostate cancer progression.

Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LW, Liang JC. Bandyk MG, et al. Among authors: pisters ll. Genes Chromosomes Cancer. 1994 Jan;9(1):19-27. doi: 10.1002/gcc.2870090105. Genes Chromosomes Cancer. 1994. PMID: 7507696

5

Biomarkers associated with prostate cancer progression.

Zhau HE, Pisters LL, Hall MC, Zhao LS, Troncoso P, Pollack A, Chung LW. Zhau HE, et al. Among authors: pisters ll. J Cell Biochem Suppl. 1994;19:208-16. J Cell Biochem Suppl. 1994. PMID: 7529853 Review.

6

Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor.

Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT. Kleinerman DI, et al. Among authors: pisters ll. Cancer Res. 1995 Mar 15;55(6):1215-20. Cancer Res. 1995. PMID: 7533659

7

c-met proto-oncogene expression in benign and malignant human prostate tissues.

Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, Chung LW. Pisters LL, et al. J Urol. 1995 Jul;154(1):293-8. J Urol. 1995. PMID: 7539865

8

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.

Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ. Navone NM, et al. Among authors: pisters ll. J Natl Cancer Inst. 1993 Oct 20;85(20):1657-69. doi: 10.1093/jnci/85.20.1657. J Natl Cancer Inst. 1993. PMID: 7692074

9

Treatment options for localized recurrence of prostate cancer following radiation therapy.

Corral DA, Pisters LL, von Eschenbach AC. Corral DA, et al. Among authors: pisters ll. Urol Clin North Am. 1996 Nov;23(4):677-84. doi: 10.1016/s0094-0143(05)70345-1. Urol Clin North Am. 1996. PMID: 8948420 Review.

10

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer.

McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, Logothetis CJ. McDonnell TJ, et al. Among authors: pisters ll. J Urol. 1997 Feb;157(2):569-74. J Urol. 1997. PMID: 8996359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters